Fourth Annual Dengue Endgame Summit
Rebecca Christofferson, MApSt, PhD

Rebecca Christofferson, MApSt, PhD

Baton Rouge, LA, USA

Associate Professor

Louisiana State University

Bio
Lab
more »
Germán Áñez, MD, FIDSA

Germán Áñez, MD, FIDSA

Bethesda, MD, USA

Executive Director, V181 Dengue vaccine product development team lead

Merck & Co., Inc.

more »
Derek Cummings, PhD

Derek Cummings, PhD

Baltimore, Maryland, USA

Professor

The Johns Hopkins University

more »
Eva Harris, PhD

Eva Harris, PhD

Berkeley, CA, USA

Professor and Chair, Division of Infectious Diseases and Vaccinology, School of Public Health; Professor, Department of Molecular and Cell Biology; Director, Center for Global Public Health

University of California, Berkeley


more »
Albert Ko, PhD

Albert Ko, PhD

New Haven, Connecticut, USA

Yale University, Raj and Indra Nooyi Professor of Public Health

Albert Ko, Yale University
more »
Nelson Michael, MD, PhD

Nelson Michael, MD, PhD

Silver Spring, Maryland, USA

Director, Center for Infectious Disease Research

Walter Reed Army Institute of Research

more »
Eng Eong Ooi, MD, PhD

Eng Eong Ooi, MD, PhD

Duke-NUS, Singapore

more »
Andre Siqueira, MD, PhD

Andre Siqueira, MD, PhD

Rio de Janeiro, Brazil

Head of Dengue Global Programme

Drugs for Neglected Diseases initiative

DNDi
more »
Stephen Thomas, MD

Stephen Thomas, MD

Syracuse, New York, USA

Director

Upstate Global Health Institute

more »
Chantal Vogels, PhD

Chantal Vogels, PhD

New Haven, Connecticut, USA

Assistant Professor

Yale School of Public Health

Vogels Lab
more »